QQ交流群

320329799

305165954

184129865

101257833

140135403

146136058

108169116

139123161

112171963

188090122

252067292

164051498

249096029

255092824

173105739

156074222

216087067

115336695

136190542

258120027

199245497

192172040

426904267

434117579

136592784

421906953

421906846

425905646

微信

医汇心血管学术 > CCRF临床试验研究项目CIT精彩呈现

CCRF临床试验研究项目CIT精彩呈现

发表于 2014-10-09 15:08:20
CCRF Clinical Trials Projects presented perfectly in CIT 2012 永铭诚道(北京)咨询有限公司CCRF 所承担的研究项目以及相关内容将在以下场次进行呈现,敬请光临!Clinical Trials Projects undertaken by CCRF and related contents will be presented in the following sessions. Welcome for your Presence.3月15日星期四 12:40 PM-1:55 PM一层多功能A厅午间卫星会 微创主办——感受火鹰,锁定未来主席:Martin B. Leon共同主席:Fausto Feres, 马长生, 沈卫峰, 徐波12:40 PM - 开场致辞12:43 PM - FIREHAWK生物可吸收聚合物西莫罗司洗脱支架:首次人体研究、TARGET I及TARGET II试验最新进展高润霖12:58 PM - TARGET I试验中FIREHAWK对比XIENCE V支架的血管镜发现陈绍良1:13 PM - TARGET I试验中FIREHAWK支架的血管内超声发现张瑞岩1:28 PM - FIREHAWK单中心经验及来自TARGET系列试验的精彩病例韩雅玲1:43 PM - 专家讨论及听众问答Luncheon SymposiumSponsored by MicroPortExperiencing FIREHAWK, Targeting the Future12:40 PM-1:55 PM, Thursday, March 15th, 2012Function A, Level 1, CNCCChairman: Martin B. LeonCo-Chairmen: Fausto Feres, Changsheng Ma, Weifeng Shen, Bo Xu12:40 PM - Opening Address12:43 PM - FIREHAWK Bioabsorbable Polymer Sirolimus-Eluting Stent: Update on the First-in-Man, TARGET I, and TARGET II TrialsRun-Lin Gao12:58 PM - Angioscopic Findings of FIREHAWK vs. XIENCE V from TARGET I TrialShaoliang Chen1:13 PM - IVUS Findings of FIREHAWK from TARGET I TrialRuiyan Zhang1:28 PM - Single Center Experience of FIREHAWK and Case Reviews from TARGET I and II TrialsYaling Han1:43 PM - Panel Discussion with Audience Q&A 3月16日 星期五 一层多功能B厅最新临床试验与特色研究首次公布(一)5:00 PM - TRACK-D:评价糖尿病患者中应用瑞舒伐他汀以预防对比剂引发急性肾损伤的安全性与有效性的大规模、多中心、随机对照试验韩雅玲5:22 PM - DK-CRUSH III:对比双挤压支架术与裙裤支架术治疗无保护左主干末端分叉病变的多中心、随机对照试验陈绍良Late Breaking Clinical Trials and First Report Investigations I5:00 PM-6:15 PM, Friday, March 16th, 2012Function B, Level 1, CNCC5:00 PM - TRACK-D: A Large-Scale, Multicenter, Randomized Trial Assessing the Safety and Efficacy for Rosuvastatin to Prevent Contrast-Induced Acute Kidney Injury in Patients with DiabetesYaling Han5:22 PM - DK-CRUSH III: A Multicenter, Randomized Trial Comparing Double Kissing (DK) Crush vs. Culotte Stenging for the Treatment of Unprotected Distal Left Main Bifurcation LesionsShaoliang Chen3月16日星期五12:40 PM-1:55 PM 一层多功能B厅午间卫星会 吉威主办——降解到天然般的健康1:05 PM - CREATE注册登记研究5年随访结果韩雅玲Luncheon SymposiumSponsored by JW MedicalBiodegradable for Natural Health12:40 PM-1:55 PM, Friday, March 16th, 2012Function B, Level 1, CNCC1:05 PM - CREATE 5-Year Update: Multi-Center Registry of EXCEL Biodegradable Polymer Drug-Eluting StentYaling Han3月17日 星期六 一层多功能B厅最新临床试验与特色研究首次公布(二)9:30 AM - CREATE:EXCEL生物可降解聚合物药物洗脱支架前瞻性、大规模、多中心注册登记研究 - 最终5年临床结果韩雅玲9:45 AM - TARGET I长支架队列:评价FIREHAWK生物可降解聚合物雷帕霉素靶向洗脱支架治疗冠状动脉长病变安全性和有效性的前瞻性、多中心研究 - 9个月造影与1年临床结果高润霖10:00 AM - FOCUS:FIREBIRD 2钴铬合金雷帕霉素洗脱支架前瞻性、大规模、多中心注册登记研究 - 2年临床结果葛均波10:30 AM - FIRE2-DIABETES:评价糖尿病患者中应用FIREBIRD 2钴铬合金雷帕霉素洗脱支架治疗复杂冠脉病变有效性与安全性的前瞻性、多中心注册登记研究 - 6个月临床结果李妍Late Breaking Clinical Trials and First Report Investigations II9:30 AM-11:00 AM, Saturday, March 17th, 2012Function B, Level 1, CNCC9:30 AM - CREATE: A Prospective, Large-Scale, Multicenter Registry of EXCEL Biodegradable Polymer Drug-Eluting Stents - Final 5-Year Clinical ResultsYaling Han10:00 AM - FOCUS: A Prospective, Large-Scale, Multicenter Registry of FIREBIRD 2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent - 2-Year Clinical ResultsJunbo Ge10:30 AM - FIRE2-DIABETES: A Prospective, Multicenter Registry Examining the Efficacy and Safety of FIREBIRD 2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent for the Treatment of Complex Coronary Lesions in Patients with Diabetes - 6-Month Clinical ResultsYan Li3月17日 星期六 12:40 PM-1:55 PM一层多功能A厅午间卫星会 雅培血管仪器部主办——DES高峰论坛:分享全球专家观点1:30 PM - SEEDS注册登记研究进展 杨跃进Luncheon SymposiumSponsored by Abbott VascularDES Summit: Sharing Global Expertise12:40 PM-1:55 PM, Saturday, March 17th, 2012Function A, Level 1, CNCC1:30 PM - SEEDS Registry UpdateYuejin Yang3月17日 星期六 12:40 PM-1:55 PM 三层311A会议室午间卫星会 微创主办——顺畅心脉,信而有证:FIREBIRD 2支架数据与经验分享12:45 PM - FOCUS临床研究两年随访结果葛均波1:00 PM - FIREBIRD 2钴铬合金西罗莫司洗脱支架在糖尿病复杂冠脉病变中的有效性及安全性研究(FIRE-DIABETES):6个月随访结果李妍Luncheon SymposiumSponsored by MicroPortSmoothing the Artery with Proven Evidence: A FIREBIRD 2 Data Review12:40 PM-1:55 PM, Saturday, March 17th, 2012Room 311A, Level 3, CNCC12:45 PM - 2-Year Follow-up Results of FOCUS StudyJunbo Ge1:00 PM - Efficacy and Safety of FIREBIRD 2 Co-Cr Sirolimus-Eluting Stent in Complex Coronary Lesions for the Treatment of Complex Coronary Lesions in Patients with Diabetes: 6-Month Clinical Results of FIRE2-DIABETESYan Li3月17日 星期六 一层多功能B厅最新临床试验与特色研究首次公布(三)3:30 PM - CREST-MI更新:急性ST段抬高型心肌梗死患者中对比CYPHER与ENDEAVOR支架安全性与有效性的多中心、随机对照试验王乐丰Late Breaking Clinical Trials and First Report Investigations III3:30 PM-5:00 PM, Saturday, March 17th, 2012Function B, Level 1, CNCC3:30 PM - CREST-MI Update: A Multicenter, Randomized Trial Comparing Safety and Efficacy of CYPHER vs. ENDEAVOR in Patients with Acute ST-Segment Elevation Myocardial InfarctionLefeng Wang 来源:
评论
热门会议推荐
申领学分

Copyright © 2014 版权所有    京ICP备12049153号-2  京ICP证140305  京公网安备11010502024544    联系E-mail:admin@zgheart.com

友情链接 医汇心脏健康网 阜外医院 掌上医讯 心内科 中国医师协会 宁夏健康网 健康时报网 互动吧 疾病大全

安全联盟站长平台 加速乐